SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-20-000137
Filing Date
2020-01-14
Accepted
2020-01-14 16:03:18
Documents
31
Period of Report
2019-11-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q cannabics_10q-113019.htm 10-Q 204711
2 CERTIFICATION cannabics_10q-ex3101.htm EX-31.1 11120
3 CERTIFICATION cannabics_10q-ex3102.htm EX-31.2 11125
4 CERTIFICATION cannabics_10q-ex3201.htm EX-32.1 5005
5 CERTIFICATION cannabics_10q-ex3202.htm EX-32.2 4936
  Complete submission text file 0001683168-20-000137.txt   858750

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE cnbx-20190331.xml EX-101.INS 52548
7 XBRL SCHEMA FILE cnbx-20190331.xsd EX-101.SCH 11560
8 XBRL CALCULATION FILE cnbx-20190331_cal.xml EX-101.CAL 27118
9 XBRL DEFINITION FILE cnbx-20190331_def.xml EX-101.DEF 11011
10 XBRL LABEL FILE cnbx-20190331_lab.xml EX-101.LAB 91508
11 XBRL PRESENTATION FILE cnbx-20190331_pre.xml EX-101.PRE 64920
Mailing Address #3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814
Business Address #3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814 877-424-2429
Cannabics Pharmaceuticals Inc. (Filer) CIK: 0001343009 (see all company filings)

IRS No.: 203373669 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 10-Q | Act: 34 | File No.: 000-52403 | Film No.: 20526080
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences